Leiden, 26 November 2020 – BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology. The company aims to use the growth hormone receptor to uniquely inhibit cancer cell growth. The investment was announced digitally by Ida Haisma, director … Meer lezen over UNIIQ invests €200,000 in novel cancer therapeutics startup BIMINI Biotech
Kopieer en plak deze URL in de WordPress-site om in te sluiten
Kopieer en plak deze code in de site om in te sluiten.